Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-2965
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women ; day:14 ; month:8 ; year:2020 ; pages:1-12
Osteoporosis international ; (14.8.2020), 1-12
- Creator
-
Chandran, M.
Ganesan, G.
Tan, K.B
Reginster, J.-Y
Hiligsmann, M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00198-020-05536-4
- URN
-
urn:nbn:de:101:1-2020100720450161838765
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chandran, M.
- Ganesan, G.
- Tan, K.B
- Reginster, J.-Y
- Hiligsmann, M.
- SpringerLink (Online service)
Other Objects (12)
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy
Cost-effectiveness thresholds or decision-making threshold: a novel perspective
Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges
An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Pediatric Vaccines and Cost-Effectiveness Thresholds: How Much is Too Much to Pay for Prevention?
Cost-Effectiveness of Targeted Reemployment Bonuses
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy
Cost-effectiveness thresholds or decision-making threshold: a novel perspective
Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges
An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Pediatric Vaccines and Cost-Effectiveness Thresholds: How Much is Too Much to Pay for Prevention?
Cost-Effectiveness of Targeted Reemployment Bonuses
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy
Cost-effectiveness thresholds or decision-making threshold: a novel perspective
Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges
An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Pediatric Vaccines and Cost-Effectiveness Thresholds: How Much is Too Much to Pay for Prevention?